Navigation Links
Neurocrine Biosciences Announces New Research Studies Presented at,APSS Reveal Significant Under-Diagnosis of Insomnia

Data Highlights the Impact of Insomnia on Healthcare System and Worker Productivity

SAN DIEGO, June 12, 2007 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. announced today that results from several research studies on the impact of chronic primary and transient insomnia were presented this week at the Associated Professional Sleep Societies (APSS) Annual Meeting. APSS highlights show that insomnia is significantly under-diagnosed and puts a significant strain on the Healthcare System and Labor Force. New data presented at APSS demonstrates the significant impact insomnia has on daytime functioning including workplace productivity, health, mood and quality of life, regardless of the type of sleep difficulty experienced.

"This research demonstrates that the impact of sleep difficulties on sufferers and the healthcare system is significant. Mounting research confirms that insomnia is a condition to be taken seriously and suggests that treating insomnia properly from the outset could reduce its subsequent impact, cost and safety consequences," said Christopher O'Brien M.D., Senior Vice President of Clinical Development and Chief Medical Officer of Neurocrine Biosciences.

    APSS Presentation Highlights:


    Study Demonstrates that Insomnia is Significantly Under-Diagnosed


    --  The purpose of this study was to examine the prevalence and clinical

        characteristics of subtypes of insomnia in the general population.

    --  According to a survey of 14,997 U.S. adults, 43.3% of respondents

        self-reported sleeping difficulties related to insomnia; compared to

        only 8.5% who met the more stringent Diagnostic and Statistic Manual

        of Mental Disorders IV (DSM-IV) criteria for primary insomnia by

        self-reported symptoms.

    --  Results found that DSM-IV insomnia appears to be under-diagnosed and

        under-treated. Additionally, there are a significant number of

        individuals with insomnia, w
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Hana Biosciences Presents Data On Two Programs At the American Society of Clinical Oncology Annual Meeting
2. Lux Biosciences Investigational Therapy for Uveitis, LX211, is Subject of Two Presentations at Key Ophthalmology Meeting, ARVO 2007
3. Hana Biosciences Announces Data to be Presented On Talvesta (Talotrexin) for Injection at The American Association for Cancer Research Annual Meeting
4. Ace Biosciences, Ace393, the Worlds First Commercial Vaccine for Travellers Diarrhoea Caused by Campylobacter Successfully Completes Phase I Clinical Trials
5. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
(Date:1/14/2014)... , Jan. 14, 2014 The Brandeis Medical Center, led ... a premier and affordable laser tattoo removal experience with ... Brandeis, focus is in providing high quality cosmetic services with cutting ... " Southern California has seen a ...
(Date:1/14/2014)... , Jan. 14, 2014 Animal Emergency Critical Care, a LifeCentre ... Leesburg, Virginia is the first in Loudoun ... Dr. Susan M. Barnes , Medical Director, ... and husband, Dr. Cole Taylor , are avid scuba divers. ...
(Date:1/14/2014)... , Jan. 14, 2014   Oligomerix, Inc. , a ... therapeutics for Alzheimer,s disease (AD) and related neurodegenerative disorders, ... Valhalla, NY as of January ... space at New York Medical College. Oligomerix, ...
Breaking Medicine Technology:Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2
... ANTONIO, Feb. 28, 2011 Advanced Cell Diagnostics, ... clinical study utilizing RNAscope™ technology to detect human ... of head and neck cancer. HPV status determined ... of patient outcome and highly concordant with that ...
... 2011 PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) ... dividend policy for 2011 and beyond and declared that the four ... be $0.15 per share of common stock.  The $0.15 dividends will ... 15 to all stockholders who own shares of PDL on March ...
Cached Medicine Technology:ACD Announces Clinical Study Results Using its RNAscope™ Technology 2ACD Announces Clinical Study Results Using its RNAscope™ Technology 3PDL BioPharma Announces Regular Quarterly Dividend Policy 2
(Date:4/18/2014)... Medicine scientists could lead to potential new treatments for ... scleroderma. , Fibrosis, or scarring, is a hallmark ... and lungs can lead to serious organ damage and, ... therapeutic options centers on findings made by Swati Bhattacharyya, ... role that a specific protein plays in promoting fibrosis. ...
(Date:4/17/2014)... relief targets that could be used to provide ... College London made the discovery when researching how ... the body. , Dr Marzia Malcangio said: "We ... generation and our findings could help chemotherapy patients ... potential side effect of some chemotherapy drugs (such ...
(Date:4/17/2014)... the University of California, San Diego School of Medicine ... have suffered a recent major loss are more likely ... , The study is published in this month,s issue ... , Because compassionate behaviors are associated with better health ... insights into ways to improve the outcomes of individuals ...
(Date:4/17/2014)... biology team has created a new technology for ... could travel the body and selectively target cancer ... biological devices that monitor and modify human physiology ... However, no existing technology enabled bioengineers to build ... and respond in a customized fashion. , "The ...
(Date:4/17/2014)... (April 16, 2014) The cause of neuronal death ... study proposes that neurons may be mistaken for foreign ... similar to the way autoimmune diseases like type I ... cells. The study was published April 16, 2014, in ... and likely controversial, idea in Parkinson,s disease; but if ...
Breaking Medicine News(10 mins):Health News:New clues on tissue scarring in scleroderma 2Health News:New pain relief targets discovered 2Health News:The ilk of human kindness 2Health News:Building 'smart' cell-based therapies 2Health News:Is Parkinson's an autoimmune disease? 2
... 2 Bob Hickman, United Feather & Down,s Senior Vice ... Inc.,s Vice President of Marketing, list their top sleep and ... four times faster than water, and its super emollient qualities ... bedding is kind to your skin to help you awaken ...
... , MIAMI, Oct. 2 The American Lung Association of ... Influenza initiative by conducting a public influenza panel discussion ... influenza and the importance of annual vaccination. The meeting will ... among high-risk groups. , The recent A (H1N1) outbreak ...
... Rising Medical Solutions, Inc. (Rising), a leading medical-financial solutions ... Company Index (PCI) "Top 10 Growth Companies" list. This ... honoree, making it the longest running Company to achieve ... , Comments Stephen H. Watkins, CEO of PCI sponsor ...
... , LEE,S SUMMIT, Mo., Oct. 2 R&D/Leverage,s ... integrated under one roof - continue to expand in ... the company,s Vice President - Engineering. , According to ... technical and engineering staff, new lean initiatives and quality-control ...
... LAS VEGAS, Oct. 2 Cord Blood America, Inc. ... cell preservation company ( http://www.cordblood-america.com ) ... cells, a biological insurance policy, to families nationwide and ... principal amount $160,000, in its continuing effort to reduce ...
... World Vision, one of the world,s leading emergency response ... be a wake-up call to the global community to fund ... agency, an expert in disaster risk reduction (DRR), works with ... to disasters like earthquakes and tsunamis, and says that DRR ...
Cached Medicine News:Health News:Ten from Two: Top Sleep and Beauty Tips from the Experts 2Health News:Ten from Two: Top Sleep and Beauty Tips from the Experts 3Health News:American Lung Association of Florida-South Area Encourages Miami Residents to See Themselves Among the Many 'Faces' of Influenza 2Health News:American Lung Association of Florida-South Area Encourages Miami Residents to See Themselves Among the Many 'Faces' of Influenza 3Health News:American Lung Association of Florida-South Area Encourages Miami Residents to See Themselves Among the Many 'Faces' of Influenza 4Health News:American Lung Association of Florida-South Area Encourages Miami Residents to See Themselves Among the Many 'Faces' of Influenza 5Health News:Rising Medical Solutions First to Achieve Six Consecutive Rankings on the Private Company Index 2Health News:R&D/Leverage Heightens Investment in Medical and Silicone Mold Manufacturing 2Health News:R&D/Leverage Heightens Investment in Medical and Silicone Mold Manufacturing 3Health News:Cord Blood America Retires Note in Continuing Effort to Reduce Debt 2Health News:World Vision Says Asian Disasters Should Be 'Wake-Up Call' For Global Leaders 2Health News:World Vision Says Asian Disasters Should Be 'Wake-Up Call' For Global Leaders 3
... SST™ Tubes contain spray-coated ... gel for serum separation. ... serum determinations in chemistry. ... efficient means of serum ...
BD Vacutainer® PST™ Tubes contain spray-coated lithium heparin and a gel for plasma separation. They are used for plasma determinations in chemistry....
MONOJECT Red/Yellow Mottled Stopper...
BD Vacutainer® Specialty Tubes - Thrombin...
Medicine Products: